Yacine Maringer

University of Tuebingen

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Susanne Rittig

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jens Bauer

Postdoc – Head of Research

Universitätsklinikum Tübingen

GERMANY

View details

Natalie Köhler

Junior Professor

University Medical Center Freiburg

GERMANY

View details

Juliane S. Walz

University Hospital Tübingen

GERMANY

View details

Philip Bucher

University of Tübingen

GERMANY

View details

Annika Nelde

University Hospital Tübingen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yacine Maringer

Research Interests

Explore related searches

Contact this professor

Articles (12)

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Collaborators (6)

Susanne Rittig

Jens Bauer

Natalie Köhler

Juliane S. Walz

Philip Bucher

Annika Nelde

Make your next move.